<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03054389</url>
  </required_header>
  <id_info>
    <org_study_id>001601</org_study_id>
    <nct_id>NCT03054389</nct_id>
  </id_info>
  <brief_title>Non-Interventional Study to Capture the Patient Experience on Gene Therapy for Hemophilia Within the AskBio009-101 Study Through Patient and Investigator Interviews</brief_title>
  <official_title>Non-Interventional Study to Capture the Patient Experience on Gene Therapy for Hemophilia Within the AskBio009-101 Study Through Patient and Investigator Interviews</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baxalta now part of Shire</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shire</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to seek to understand the patient's perspective around deciding
      to participate in a clinical trial for a Hemophilia therapy
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 31, 2017</start_date>
  <completion_date type="Actual">June 6, 2017</completion_date>
  <primary_completion_date type="Actual">June 6, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Interview - AskBio009-101 Study - Participants/ Patients</measure>
    <time_frame>Approximately 1 hour</time_frame>
    <description>Qualitative telephone interviews to understand the patient experience with the AskBio009-101 Study - Participant/ Patient Interview</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Interview - AskBio009-101 Study - Investigators and Study Coordinators</measure>
    <time_frame>Approximately 1 hour</time_frame>
    <description>Qualitative telephone interviews to understand the patient experience with the AskBio009-101 Study - Investigators and Study Coordinators Interview</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">27</enrollment>
  <condition>Hemophilia B</condition>
  <arm_group>
    <arm_group_label>Participants/ Patients</arm_group_label>
    <description>Participants/ Patients from the AskBio009-101 Study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Investigators and Study Coordinators</arm_group_label>
    <description>Investigators and Study Coordinators from the AskBio009-101 Study</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Qualitative Interview - Participants/ Patients</intervention_name>
    <description>Qualitative interviews to understand the patient experience with the AskBio009-101 Study - Participants/ Patients</description>
    <arm_group_label>Participants/ Patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Qualitative Interview - Investigators and Study Coordinators</intervention_name>
    <description>Qualitative interviews to understand the patient experience with the AskBio009-101 Study - Investigators and Study Coordinators</description>
    <arm_group_label>Investigators and Study Coordinators</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Investigators, Study Coordinators, and Participants from the AskBio009-101 Study
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria for patients:

          -  Were screened and consented for the AskBio009-101study at any point in time

          -  Are able to speak and understand English

          -  Are between ages of 18 and 75

          -  Are physically able to participate in a one-hour phone interview

          -  Consented into this study independently of the AskBio009-101 study

        Exclusion criteria for patients:

        - N/A

        Inclusion criteria for investigators and coordinators:

          -  Worked at a site as an investigator or study coordinator that consented a patient into
             the

          -  AskBio009-101 trial at any point in time, including those that no longer work at a
             AskBio009-101 site

          -  Are able to speak and understand English

          -  Are between ages of 18 and 75

          -  Are physically able to participate in a one-hour phone interview

        Exclusion criteria for investigators and coordinators:

        - Not directly involved in the consent process at the gene therapy site
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Chapin, MD</last_name>
    <role>Study Director</role>
    <affiliation>Baxalta now part of Shire</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>QuintilesIMS</name>
      <address>
        <city>Cambridge</city>
        <state>Massachusetts</state>
        <zip>02139</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2017</study_first_submitted>
  <study_first_submitted_qc>February 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2017</study_first_posted>
  <last_update_submitted>October 19, 2017</last_update_submitted>
  <last_update_submitted_qc>October 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemophilia A</mesh_term>
    <mesh_term>Hemophilia B</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

